Exact Mass: 352.2049766
Exact Mass Matches: 352.2049766
Found 500 metabolites which its exact mass value is equals to given mass value 352.2049766,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tebufenozide
CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4696; ORIGINAL_PRECURSOR_SCAN_NO 4694 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4687; ORIGINAL_PRECURSOR_SCAN_NO 4683 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9485; ORIGINAL_PRECURSOR_SCAN_NO 9481 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4702; ORIGINAL_PRECURSOR_SCAN_NO 4700 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4698; ORIGINAL_PRECURSOR_SCAN_NO 4696 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9523; ORIGINAL_PRECURSOR_SCAN_NO 9521 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9469; ORIGINAL_PRECURSOR_SCAN_NO 9467 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4672; ORIGINAL_PRECURSOR_SCAN_NO 4668 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9480; ORIGINAL_PRECURSOR_SCAN_NO 9479 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4704; ORIGINAL_PRECURSOR_SCAN_NO 4703 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9513; ORIGINAL_PRECURSOR_SCAN_NO 9510 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9506; ORIGINAL_PRECURSOR_SCAN_NO 9503 D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
Clidinium
C22H26NO3+ (352.1912586000001)
Clidinium is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract. It inhibits muscarinic actions of acetylcholine at postganglionic parasympathetic neuroeffector sites. It is used for the treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome. C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
Encainide
All drug products containing encainide hydrochloride. Encainide hydrochloride, formerly marketed as Enkaid capsules, was associated with increased death rates in patients who had asymptomatic heart rhythm abnormalities after a recent heart attack. The manufacturer of Enkaid capsules voluntarily withdrew the product from the US market on December 16, 1991. C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BC - Antiarrhythmics, class ic D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
1-(4-Amino-5-chloro-2-methoxyphenyl)-3-(1-butyl-4-piperidinyl)-1-propanone
Anileridine
Anileridine is a synthetic opioid and strong analgesic medication. It is a narcotic pain reliever used to treat moderate to severe pain. Narcotic analgesics act in the central nervous system (CNS) to relieve pain. Some of their side effects are also caused by actions in the CNS. N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general > N01AH - Opioid anesthetics C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
[4]-Gingerdiol 3,5-diacetate
[4]-Gingerdiol 3,5-diacetate is found in herbs and spices. [4]-Gingerdiol 3,5-diacetate is a constituent of ginger (Zingiber officinale).
Methyl (9Z)-8'-oxo-6,8'-diapo-6-carotenoate
Methyl (9Z)-8-oxo-6,8-diapo-6-carotenoate is a constituent of Bixa orellana (annatto) Constituent of Bixa orellana (annatto).
2-(4-Hydroxy-3,5-di-tert-butylphenylthio)-hexanoic acid
Leptin F
Phenothiazine, 10-((N-butyl-2-piperidyl)methyl)-
C22H28N2S (352.19730880000003)
Posatirelin
11,17-Dihydroxy-6-methyl-17-(1-propynyl)androsta-1,4,6-triene-3-one
2,3-Dimethoxy-5-methyl-6-(9'-carboxynonyl)-1,4-benzoquinone
2-Methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
8-Hydroxy-9-isobutyryloxy-10(2)-methylbutyrylthymol
6,10-Bis(acetoxymethyl)-12-hydroxy-2-methyl-2,6,10-dodecatrienal
13beta,14-Diacetoxy-9(12)-capnellene-8beta,10alpha-diol
2beta,5alpha-Diacetoxy-9(12)-capnellene-8beta,10alpha-diol
3-[(E)-3,4-dihydroxy-3,5-dimethylhept-1-enyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1H-isochromen-6-one
methyl 6-deoxy-1,3-di-O-methyl-beta-D-ribo-hexosyl-(1->4)-2,6-dideoxy-3-O-methyl-alpha-D-arabino-hexopyranoside
4beta,10alpha-dihydroxy-3-oxo-8beta-isobutyryloxyguaia-11(13)-en-12,6alpha-olide
MEGxp0_001143
2-Methylbutyric acid 10-(isobutyryloxy)-8-hydroxythymol-9-yl ester is a natural product found in Arnica montana with data available.
(8E,16S)-16-Hydroxy-8-tricosene-4,6,17,19-tetraynoic acid
Bis(isobutyric acid)2-hydroxy-2-(2-methoxy-4-methylphenyl)-1,3-propanediyl ester
2beta,16alpha,17-trihydroxy-ent-kauran-19-oic acid
5-oxo-15,18(R and S),19-trihydroxyspata-13,16(E)-diene
3beta,16alpha,17-trihydroxy-ent-kauran-19-oic acid
(4beta,10E)-6alpha,14,15-trihydroxy-8beta-(isobutyryloxy)germacra-10,11,(13)-diene-12-oic acid 12,6-lactone|14,15-dihydroxy-8beta-isobutyryloxygermacra-1(10)E,11(13)-dien-12,6alpha-olide
2alpha,15R,16-trihydroxy-8(14)-isopimarene-18-oic acid|wulingzhic acid A
8beta,10beta-dihydroxy-6beta-isobutyryloxyeremophil-7(11)-en-(12,8)-olide
16xi-Hydroxy-3,4-Dihydroxy-13-cleroden-15,16-olide|3alpha,4beta,16-trihydroxy-5beta,10beta-cis-17alpha,20alpha-cleroda-13(14)-en-15,16-olide
all-E-citreomontanin|Citreomontanin|citreomontanine
2-(7-hydroxy-1-oxooctyl)-3-hydroxy-5-methoxybenzeneacetic acid ethyl ester
2-isoprenyl-5-isopropylphenyl 4-O-beta-D-xylopyranoside
(1S*,3R*,4S*,6R*,7R*,8R*,11Z)-4,6,8-trihydroxy-11-capnosene-2,10-dione
1beta-hydroperoxy-3beta-hydroxy-8alpha-isobutyryloxygermacra-4E,10(14),11(13)-trien-12,6alpha-olide
Lipoxin A4
A C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds. D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Chemical was purchased from CAY90410 (Lot D433602-40); Diagnostic ions: 351.2, 251.1, 235,1, 145.6, 114.9
Tebufenozide
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 2952 EAWAG_UCHEM_ID 2952; CONFIDENCE standard compound
ANILERIDINE
N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general > N01AH - Opioid anesthetics C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
3-[(E)-3,4-dihydroxy-3,5-dimethylhept-1-enyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1H-isochromen-6-one
LXA4-[19,19,20,20,20-d5]
Chemical was purchased from CAY10007737 (Lot. 0410966-34); Diagnostic ions: 356.1, 251.0, 240.2, 115.0
PGE2-[3,3,4,4-d4]
Chemical was purchased from CAY314010 (Lot 0437217-27); Diagnostic ions: 355.0, 337.3, 275.2, 193.0
[(1R,2S,3S,4R,4aS)-2,3-dihydroxy-3,4a,8,8-tetramethyl-4-[(E)-3-oxobut-1-enyl]-2,4,5,6,7,8a-hexahydro-1H-naphthalen-1-yl] acetate
CA6PE2C
Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); The position of the carboxylic group was assigned arbitrarily; locations of branching points are undetermined; Digitised from figure: approximate intensities
PGE2-[d9]
CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0164.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0164.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0164.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001321.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001321.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001321.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001321.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001321.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001321.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
Prostacyclin
CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0196.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0196.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0196.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000127.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000127.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000127.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000127.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000127.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000127.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
PGD2-[d4]
CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0151.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0151.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0151.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001311.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001311.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001311.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001311.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001311.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001311.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
PGE2-[d4]
CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0241.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0241.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0241.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001313.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001313.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001313.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001313.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001313.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001313.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
9,13-Epoxy-3,18-dihydroxy-15,16-labdanolide
Origin: Plant; SubCategory_DNP: Diterpenoids, Labdane diterpenoids
[(1R,2S,3S,4R,4aS)-2,3-dihydroxy-3,4a,8,8-tetramethyl-4-[(E)-3-oxobut-1-enyl]-2,4,5,6,7,8a-hexahydro-1H-naphthalen-1-yl] acetate_major
3-[(E)-3,4-dihydroxy-3,5-dimethylhept-1-enyl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1H-isochromen-6-one_major
1-ethyl-4-[2-(2-hydroxyethylamino)ethyl]-3,3-diphenylpyrrolidin-2-one
13,14-dihydro-15-keto-PGD2
5,14,15-trihydroxy-6,8,10,12-Eicosatetraenoic acid
Apo-8'-bixinal
Sterebin B
Sterebin C
(ent-6alpha,7alpha,16alphaH)-6,7,17-Trihydroxy-19-kauranoic acid
3-[(1E)-3,4-Dihydroxy-3,5-dimethyl-1-hepten-1-yl]-7,8-dihydroxy-7-methyl-1,7,8,8a-tetrahydro-6H-isochromen-6-one
FA 20:4;O3
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Prostin E2
G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AD - Prostaglandins D012102 - Reproductive Control Agents > D010120 - Oxytocics C78568 - Prostaglandin Analogue Prostaglandin E2 (PGE2) is a hormone-like substance that participate in a wide range of body functions such as the contraction and relaxation of smooth muscle, the dilation and constriction of blood vessels, control of blood pressure, and modulation of inflammation.
Prostaglandin D2
A member of the class of prostaglandins D that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,9alpha,13E,15S- stereoisomer).
Prostaglandin H2
D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
lipoxin B4
A C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds. D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
5-E2t-IsoP
Ectocarpin D
1-PYRROLIDIN-3-PHENYL-3-(N-CBZ-N-METHYL)AMINO-ETHANE
7-((1R,2R,3R)-3-HYDROXY-2-((S,1E,5E)-3-HYDROXYOCTA-1,5-DIEN-1-YL)-5-OXOCYCLOPENTYL)HEPTANOIC ACID
Posatirelin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76367 - Thyrotropin-Releasing Hormone Analogue D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
1-BENZYL-3-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)UREA
C20H25BN2O3 (352.19581299999993)
3-(3,4,5-TRIMETHOXY-PHENYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
CYCLOHEXANONE, 4-[[(1,1-DIMETHYLETHYL)DIPHENYLSILYL]OXY]-
Aluminum,bis(2-butanolato)(triethyl orthosilicato-kO)-
C14H33AlO6Si (352.18617079999996)
(2R,4R)-BOC-4-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID BENZYLAMINE SALT
tert-butyl 1-benzhydrylazetidin-3-yl(Methyl)carbamate
N-[1-[2-(4-hydroxyphenyl)ethyl]piperidin-4-yl]-N-phenylpropanamide
N-Isopropyl-3,5-dimethoxy-4-(2-morpholinoethoxy)benzamide
ETHYL 3-((7-ETHOXY-7-OXOHEPTYL)OXY)-4-METHOXYBENZOATE
N-[1-(1-hydroxy-2-phenylethyl)piperidin-4-yl]-N-phenylpropanamide
butyl prop-2-enoate,ethyl prop-2-enoate,prop-2-enamide,prop-2-enenitrile
Valomaciclovir
C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent
(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3R)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid
(E)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid
7,9a-Methano-9aH-cyclopenta[b]heptalene-2,8,11,11a,12(1H)-pentol, dodecahydro-1,1,8-trimethyl-4-methylene-, (2S,3aS,4aS,7R,8R,9aS,11R,11aR,12R)-
(1R,2R,5R,6S,8aS)-6-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-octahydro-2H-dispiro[naphthalene-1,2:5,3-bis(oxolane)]-5-one
methyl (3S)-3-(3-carbamimidoylphenyl)-5-(4-carbamimidoylphenyl)pentanoate
C20H24N4O2 (352.18991639999996)
[4]-Gingerdiol 3,5-diacetate
[4]-gingerdiol 3,5-diacetate is a member of the class of compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. [4]-gingerdiol 3,5-diacetate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). [4]-gingerdiol 3,5-diacetate can be found in herbs and spices, which makes [4]-gingerdiol 3,5-diacetate a potential biomarker for the consumption of this food product. [4]-Gingerdiol 3,5-diacetate is found in herbs and spices. [4]-Gingerdiol 3,5-diacetate is a constituent of ginger (Zingiber officinale).
3-(3,4-Dihydroxy-3,5-dimethylhept-1-enyl)-7,8-dihydroxy-7-methyl-8,8a-dihydro-1H-isochromen-6-one
[2,3-Dihydroxy-3,4a,8,8-tetramethyl-4-(3-oxobut-1-enyl)-2,4,5,6,7,8a-hexahydro-1H-naphthalen-1-yl] acetate
N-(4-methoxyphenyl)-N-[2-(6-methylpyridin-2-yl)ethyl]cyclohexanecarboxamide
(5S,15S)-5-hydroperoxy-15-HETE
A 5-hydroperoxy-15-HETE stereoisomer that has 5S,15S configuration.
(5S,7E,9E,11Z,13E,15S)-15-hydroperoxy-5-hydroxyicosa-7,9,11,13-tetraenoic acid
(5S,6E,8Z,11Z,13E,15R)-5-hydroperoxy-15-hydroxyicosa-6,8,11,13-tetraenoic acid
7-[(1R,2R,3R)-3-Hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]-5-heptenoic acid
5,6,15-Trihydroxy-7,9,11,13-eicosatetraenoic acid
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
5-hydroperoxy-15-HETE
An icosanoid that is (6E,8Z,11Z,13E)-icosa-6,8,11,13-tetraenoic acid substituted at positions 5 and 15 by hydroperoxy and hydroxy groups respectively.
(6E,8E,10E,14E)-5,12,20-trihydroxyicosa-6,8,10,14-tetraenoic acid
(5E)-5-[5-hydroxy-4-[(E)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
11,17-dihydroxy-6,10,13-trimethyl-17-prop-1-ynyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one
(E)-7-[5-hydroxy-3-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid
4-(3,5-dimethyl-1-piperidinyl)-N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-4-oxobutanamide
(5S)-hydroperoxy-(14R,15S)-epoxy-(6E,8Z,11Z)-icosatrienoic acid
A hydroperoxy fatty acid that is (14R,15S)-epoxy-(6E,8Z,11Z)-icosatrienoic acid in which the hydroperoxy group is located at position 5S.
(8S)-hydroperoxy-(14S,15R)-epoxy-(5Z,9E,11Z)-icosatrienoic acid
A hydroperoxy fatty acid that is (14S,15R)-epoxy-(5Z,9E,11Z)-icosatrienoic acid in which the hydroperoxy group is located at position 8S.
(12S)-hydroperoxy-(14R,15S)-epoxy-(5Z,8Z,10E)-icosatrienoic acid
A hydroperoxy fatty acid that is (14R,15S)-epoxy-(5Z,8Z,10E)-icosatrienoic acid in which the hydroperoxy group is located at position 12S.
(12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoic acid
A hydroperoxy fatty acid that is (14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoic acid in which the hydroperoxy group is located at position 12S.
20-hydroxy-6-trans-leukotriene B4
A member of the class of leukotrienes that is 6-trans-leukotriene B4 bearing an additional hydroxy substituent at position 20.
10-(3-Carboxypropyl)-3,6-bis(dimethylamino)acridinium
C21H26N3O2+ (352.20249160000003)
(5S,6Z,8E,10E,12R,14Z)-5,12,18-trihydroxyicosa-6,8,10,14-tetraenoic Acid
(1R,3R,4S,11S,12R)-3,4,11-trihydroxy-4,8,12-trimethyl-15-methylidene-13-oxabicyclo[10.3.2]heptadec-7-en-14-one
(E)-7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-(4-phenylphenyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide
N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[[(2S,3S,4S)-4-(hydroxymethyl)-3-(4-phenylphenyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide
N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-4-oxanecarboxamide
N-[[(2R,3R,4R)-4-(hydroxymethyl)-3-(4-phenylphenyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide
N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-(4-phenylphenyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide
(5S,6E,8Z,11Z,13E,15S)-15-hydroperoxy-5-hydroxyicosa-6,8,11,13-tetraenoic acid
Methyl (9R,18R,21S)-2-methyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate
(5Z,8Z,11Z)-12-[(1S,2R,3R,5R)-2,3-dihydroxy-5-[(1S)-1-hydroxypropyl]cyclopentyl]dodeca-5,8,11-trienoic acid
(13E,15S)-15,20-dihydroxy-9-oxoprosta-10,13-dien-1-oic acid
(E)-7-[(1S,2S,5S)-5-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid
methyl (1R,16R,18R,21S)-2-methyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate
(9R,17S)-9-fluoro-6,11,17-trihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
(5S,6E,8Z,10E,12S,14Z)-5-hydroperoxy-12-hydroxyicosa-6,8,10,14-tetraenoic acid
Dinoprostone
G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AD - Prostaglandins D012102 - Reproductive Control Agents > D010120 - Oxytocics C78568 - Prostaglandin Analogue Prostaglandin E2 (PGE2) is a hormone-like substance that participate in a wide range of body functions such as the contraction and relaxation of smooth muscle, the dilation and constriction of blood vessels, control of blood pressure, and modulation of inflammation.
Encainide
C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BC - Antiarrhythmics, class ic D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
clidinium
C22H26NO3+ (352.1912586000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics
(1R,2R,3S,6S,10S,11S,13S,14S)-11-(1-Hydroxypropan-2-yl)-3,7,10-trimethyl-15-oxapentacyclo[7.5.1.02,6.07,13.010,14]pentadecane-3,9,14-triol
(1R,2S,3S,4S,6R,10S,11S,13S,14S)-3,7,10-Trimethyl-11-propan-2-yl-15-oxapentacyclo[7.5.1.02,6.07,13.010,14]pentadecane-4,6,9,14-tetrol
15-epi-lipoxin A4
A C20 hydroxy polyunsaturated fatty acid having (5S)-, (6R)- and (15R)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
15-Epi-lipoxin b4
A C20 hydroxy fatty acid having (5S)-, (14R)- and (15R)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
6-epi-lipoxin A4
A C20 hydroxy fatty acid having (5S)-, (6S)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
8-isoprostaglandin E2
D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents
9S,11R-dihydroxy-15-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R]
15-oxo-5S,6R-dihydroxy-7E,9E,11Z-eicosatrienoic acid
18-hydroxyleukotriene B4
A leukotriene that is leukotriene B4 carrying an additional hydroxy substituent at position 18.
(5S)-hydroxy-(15S)-hydroperoxy-(6E,8Z,11Z,13E)-icosatetraenoic acid
A hydroperoxy(hydroxy)icosatetraenoic acid that is (6E,8Z,11Z,13E)-icosatetraenoic acid in which the hydroxy and hydroperoxy substituents are located at positions 5S and 15S respectively.
8-epi-prostaglandin E2
A prostanoid that is prostaglandin E2 having inverted stereochemistry at the 8-position.
19-hydroxyleukotriene B4
A leukotriene that is leukotriene B4 carrying an additional hydroxy substituent at position 19.
13,14-dihydro-15-oxolipoxin A4
A C20 hydroxy fatty acid obtained by formal hydrogenation across the 13,-14-double bond of 15-oxolipoxin A4.
13,14-dihydro-15-oxo-prostaglandin E2
The 13,14-dihydro derivative of 15-oxo-prostaglandin E2.
Prostaglandin E2
Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins.
DG(17:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
4-methoxy-5-methyl-6-(7,9,11-trimethyltrideca-1,3,5,7,9,11-hexaen-1-yl)pyran-2-one
(2r)-2-hydroxy-2-(2-hydroxy-4-methylphenyl)-3-[(2-methylpropanoyl)oxy]propyl (2r)-2-methylbutanoate
(1s,5s)-5-hydroxy-4-oxo-5-tridecanoylcyclopent-2-en-1-yl acetate
(1s,2r,4s,5s,9r,10s,13s,14r,15r,16r)-2,15,16-trihydroxy-5-(hydroxymethyl)-5,9,14-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-12-one
8a,9a-dihydroxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,9h-naphtho[2,3-b]furan-4-yl 2-methylpropanoate
7-[(1r,2r,5s)-5-hydroxy-2-[(1e,3s)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid
(3as,5ar,6r,8r,9s,9as,9bs)-6,9-dihydroxy-5a,9-dimethyl-3-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-8-yl 2-methylpropanoate
(4s,5e,7s,10r,11r,13s)-7,10,11-trihydroxy-4-isopropyl-7,11-dimethyl-14-oxabicyclo[11.2.1]hexadeca-1(16),5-dien-15-one
4-hydroxy-1-[5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1-(hydroxymethyl)-2,5-dimethyl-2,3,4,7,8,8a-hexahydroazulene-3a-carbaldehyde
6-hydroxy-5-(5-hydroxy-3-methylidene-4-oxopentyl)-1,4a,6-trimethyl-hexahydro-2h-naphthalene-1-carboxylic acid
(7s,8s,8as)-3-[(1e,3s,4s,5r)-3,4-dihydroxy-3,5-dimethylhept-1-en-1-yl]-7,8-dihydroxy-7-methyl-8,8a-dihydro-1h-isochromen-6-one
5-hydroxy-4-oxo-5-tridecanoylcyclopent-2-en-1-yl acetate
(3s,4r,5e,9s,10r,11e,13s,14s)-14-ethyl-4,10-dihydroxy-3,5,9,11,13-pentamethyl-1-oxacyclotetradeca-5,11-diene-2,7-dione
methyl 8-[(5r)-2-[(2r)-2-hydroxypent-3-en-1-yl]-5-methoxy-3-oxocyclopent-1-en-1-yl]octanoate
(2e,6r)-6-[(4e)-6-hydroxy-4-methylhex-4-en-1-yl]-2-(4-methylpent-3-en-1-yl)hept-2-enedioic acid
(2s,3s,3ar,5ar,6r,7r,10ar)-8-(hydroxymethyl)-1-isopropyl-3a,5a-dimethyl-2h,3h,4h,5h,6h,7h,10h,10ah-cyclohepta[e]indene-2,3,6,7-tetrol
7-[(1r,2r,3r)-3-hydroxy-2-[(1e,3s)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid
methyl (6e,8e,10e,12e,14e,16e)-4,8,13,17-tetramethyl-18-oxooctadeca-2,4,6,8,10,12,14,16-octaenoate
(3r,5s)-5-(acetyloxy)-1-(4-hydroxy-3-methoxyphenyl)octan-3-yl acetate
(2e)-4-[(1r,5r,6r)-3-heptyl-5-hydroxy-4-(hydroxymethyl)-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-2-methylbut-2-enoic acid
(2e,10z,14e)-1,16-dihydroxy-3,11-bis(hydroxymethyl)-15-methyl-7-methylidenehexadeca-2,10,14-trien-6-one
4-[2-(5,6-dihydroxy-1,2,4a,5-tetramethyl-hexahydro-2h-naphthalen-1-yl)ethyl]-5-hydroxy-5h-furan-2-one
3,4,11-trihydroxy-4,8,12-trimethyl-15-methylidene-13-oxabicyclo[10.3.2]heptadec-7-en-14-one
(1s,3r,3as,5's,7as)-4,4,5',7a-tetramethyl-3-(2-oxopropyl)-tetrahydro-3h-spiro[2-benzofuran-1,2'-oxolan]-5'-ylacetic acid
(2s,3r,4s,5r)-2-[4-hydroxy-2-isopropyl-5-(3-methylbut-2-en-1-yl)phenoxy]oxane-3,4,5-triol
(1r,2r,3ar,4r,8ar)-4-hydroxy-1-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1-(hydroxymethyl)-2,5-dimethyl-2,3,4,7,8,8a-hexahydroazulene-3a-carbaldehyde
(1r,2s,4s,4as,5'r,5''s,8as)-4,5''-dihydroxy-2,5,5,8a-tetramethyl-hexahydrodispiro[naphthalene-1,2':5',3''-bis(oxolane)]-3-one
(1r,4as,4br,7r,8r,8ar,9s,10ar)-7-ethenyl-8,8a,9-trihydroxy-1,4a,7-trimethyl-decahydrophenanthrene-1-carboxylic acid
5-(4-carboxy-3-methylbutyl)-7-hydroxy-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid
(1ar,2s,2as,5's,6as,7ar)-1a-(hydroxymethyl)-2a,5',6,6-tetramethyl-hexahydrospiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-ylacetic acid
3-(acetyloxy)-2-hydroxypropyl 3,7,11-trimethyldodeca-2,6,10-trienoate
(1r,2z,4r,8r,9r,11r,12r)-1,12-dihydroxy-2,11-dimethyl-7-methylidene-9-(2-methylpropoxy)-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-6-one
5-(4-carboxy-3-methylbutyl)-8a-(hydroxymethyl)-5,6-dimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid
(3ar,4r,6s,9s,11ar)-6,9-dihydroxy-6,10-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
(3s,5s)-1-(3,4-dimethoxyphenyl)-5-hydroxydecan-3-yl acetate
(12r)-17-(ethoxymethyl)-12-ethyl-8,16-diazatetracyclo[10.6.1.0²,⁷.0¹⁶,¹⁹]nonadeca-1(19),2,4,6,8,17-hexaen-9-ol
(5s,6r,13e,15s)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid
(2e)-5-[(4r,4ar,5s,6r,8as)-4,6-dihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid
3-{2-[(1r,2s,4as,8as)-2,5,5-tris(hydroxymethyl)-8a-methyl-octahydronaphthalen-1-yl]ethyl}-5h-furan-2-one
(1r,4s,6s,10s,13s,14r,17s)-10,13-dihydroxy-4,13,17-trimethyl-9-methylidene-5,15-dioxatricyclo[12.3.1.0⁴,⁶]octadecan-16-one
(1r,2r,3s,4s,5r,9s,10s,13r,14r)-2,3-dihydroxy-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
7-[3,5-dihydroxy-2-(3-oxooct-1-en-1-yl)cyclopentyl]hept-5-enoic acid
6,9a-dihydroxy-3,5a-dimethyl-9-methylidene-2-oxo-octahydronaphtho[1,2-b]furan-4-yl 2-methylpropanoate
1-(4-hydroxy-3-methoxyphenyl)-3,5-diacetoxy-octane
{"Ingredient_id": "HBIN001477","Ingredient_name": "1-(4-hydroxy-3-methoxyphenyl)-3,5-diacetoxy-octane","Alias": "NA","Ingredient_formula": "C19H28O6","Ingredient_Smile": "CCCC(CC(CCC1=CC(=C(C=C1)O)OC)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15879","TCMID_id": "10435","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
15-epileopersin c
{"Ingredient_id": "HBIN001673","Ingredient_name": "15-epileopersin c","Alias": "NA","Ingredient_formula": "C20H32O5","Ingredient_Smile": "CC1C(C(=O)C2C(CCCC2(C13CCC4(O3)CC(OC4)O)C)(C)C)O","Ingredient_weight": "352.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15263","TCMID_id": "6946","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "15548655","DrugBank_id": "NA"}
15-epi-leopersin j
{"Ingredient_id": "HBIN001674","Ingredient_name": "15-epi-leopersin j","Alias": "NA","Ingredient_formula": "C20H32O5","Ingredient_Smile": "CC1C(=O)C(C2C(CCCC2(C13CCC4(O3)CC(OC4)O)C)(C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6947","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β,15xi,16-trihydroxy-isopimaricacid
{"Ingredient_id": "HBIN008021","Ingredient_name": "3\u03b2,15xi,16-trihydroxy-isopimaricacid","Alias": "NA","Ingredient_formula": "C20H32O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21736","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-hydroxyportulol ether; 3-deoxy,19-oxo
{"Ingredient_id": "HBIN008742","Ingredient_name": "3-hydroxyportulol ether; 3-deoxy,19-oxo","Alias": "NA","Ingredient_formula": "C20H32O5","Ingredient_Smile": "NA","Ingredient_weight": "352.47","OB_score": "NA","CAS_id": "98263-93-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8073","PubChem_id": "NA","DrugBank_id": "NA"}